Immunisation against respiratory syncytial virus (RSV) will be offered by the NHS in UK for the first time from September 1st 2024 to those turning 75 years of age.
It will be a year-round offer for those aged 75, alongside a catchup programme for those aged 75 – 79 years of age. The vaccines offered for these age groups are called Abrysvo and Arexvy.
The Abrysvo vaccine will also be offered to pregnant women from the 28th week of pregnancy.
Abrysvo and Arexvy are not ‘live’ vaccines, so they can be given to people who are taking immunosuppressant treatment. Note that the response to any permitted vaccine is likely to be less than expected if a person is on immunosuppressant treatment. More information: https://www.nhs.uk/conditions/respiratory-syncytial-virus-rsv/